의약품 관련 법령
Drug and Device Manufacturer Communications With Payors, Formulary Committees, and Similar Entities – Questions and Answers Guidance for Industry and Review Staff
작성자 | 관리자 | ||
---|---|---|---|
작성일 | 2018-07-31 | 조회수 | 622 |
국가정보 | 북 아메리카>미국 | ||
출처 | FDA | ||
원문 | https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM537347.pdf | ||
첨부파일 |
Drug and Device Manufacturer Communications With Payors, Formulary Committees, and Similar Entities – Questions and Answers Guidance for Industry and Review Staff
- 이전글 Pre-ion Drug User Fee Act Waivers for Fixed-Combination Antiretroviral Drugs for the President’s Emergency Plan for AIDS Relief
- 다음글 Medical Product Communications That Are Consistent With the FDA-Required Labeling — Questions and Answers Guidance for Industry